Forbes January 13, 2025
Surbhi Sarna sold her last startup, nVision Medical, for $275 million. Now she’s leaving a partner role at Y Combinator to launch Collate, a startup aiming to automate the tedious parts of running a life sciences business.
When Surbhi Sarna set out to raise funding for her ovarian cancer detection startup more than a decade ago, she faced a lengthy struggle. A solo founder not long out of college at the time, she scraped together $500,000 for nVision Medical in 18 months and got to work. nVision had raised just $17 million total by the time Sarna sold it to medical device giant Boston Scientific for $275 million in 2018.
It’s a different story with Sarna’s second startup, Collate, announced...
Today's Sponsors
Today's Sponsor